These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1336070)

  • 1. A comparison study of treated and untreated pregnant and postpartum cocaine-abusing women.
    Smith IE; Dent DZ; Coles CD; Falek A
    J Subst Abuse Treat; 1992; 9(4):343-8. PubMed ID: 1336070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addiction severity, psychopathology and treatment compliance in cocaine-dependent mothers.
    Killeen TK; Brady KT; Thevos A
    J Addict Dis; 1995; 14(1):75-84. PubMed ID: 7632749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of substance use outcomes in demonstration projects for pregnant and postpartum women and their infants: findings from a quasi-experiment.
    Eisen M; Keyser-Smith J; Dampeer J; Sambrano S
    Addict Behav; 2000; 25(1):123-9. PubMed ID: 10708327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographic and psychosocial characteristics of substance-abusing pregnant women.
    Hans SL
    Clin Perinatol; 1999 Mar; 26(1):55-74. PubMed ID: 10214543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased psychological distress in post-partum, cocaine-using mothers.
    Singer L; Arendt R; Minnes S; Farkas K; Yamashita T; Kliegman R
    J Subst Abuse; 1995; 7(2):165-74. PubMed ID: 7580227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of intensive case-managed intervention on substance-using pregnant and postpartum women.
    Lanehart RE; Clark HB; Rollings JP; Haradon DK; Scrivner L
    J Subst Abuse; 1996; 8(4):487-95. PubMed ID: 9058361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of pregnancy on psychoactive substance use among women with substance use disorders recruited in addiction specialized care centers in France.
    Pochard L; Dupouy J; Frauger E; Giocanti A; Micallef J; Lapeyre-Mestre M;
    Fundam Clin Pharmacol; 2018 Apr; 32(2):188-197. PubMed ID: 29337399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case management of pregnant and parenting female crack and polydrug abusers.
    Lanehart RE; Clark HB; Kratochvil D; Rollings JP; Fidora AF
    J Subst Abuse; 1994; 6(4):441-8. PubMed ID: 7780302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linking substance-abusing pregnant women to drug treatment services: a pilot program.
    Corrarino JE; Williams C; Campbell WS; Amrhein E; LoPiano L; Kalachik D
    J Obstet Gynecol Neonatal Nurs; 2000; 29(4):369-76. PubMed ID: 10929840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychoactive substance use during pregnancy: a review].
    Lamy S; Thibaut F
    Encephale; 2010 Feb; 36(1):33-8. PubMed ID: 20159194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unique drug treatment program for pregnant and postpartum substance-using women in New York City: results of a pilot project, 1990-1995.
    McMurtrie C; Rosenberg KD; Kerker BD; Kan J; Graham EH
    Am J Drug Alcohol Abuse; 1999 Nov; 25(4):701-13. PubMed ID: 10548443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of cocaine addiction during pregnancy.
    Farkas KJ; Parran TV
    Clin Perinatol; 1993 Mar; 20(1):29-45. PubMed ID: 8458170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Psychosocial factors predicting postnatal anxiety symptoms and their relation to symptoms of postpartum depression].
    Navarrete LE; Lara-Cantú MA; Navarro C; Gómez ME; Morales F
    Rev Invest Clin; 2012; 64(6 Pt 2):625-33. PubMed ID: 23593781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in cocaine dependent patients: a 6 month follow-up study.
    Weiss RD; Martinez-Raga J; Griffin ML; Greenfield SF; Hufford C
    Drug Alcohol Depend; 1997 Jan; 44(1):35-40. PubMed ID: 9031818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics of perinatal psychiatric patients: a chart review study.
    Battle CL; Zlotnick C; Miller IW; Pearlstein T; Howard M
    J Nerv Ment Dis; 2006 May; 194(5):369-77. PubMed ID: 16699387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment retention and birth outcomes of crack users enrolled in a substance abuse treatment program for pregnant women.
    Fiocchi FF; Kingree JB
    J Subst Abuse Treat; 2001 Mar; 20(2):137-42. PubMed ID: 11306216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A five-factor model of personality and addiction, psychiatric, and AIDS risk severity in pregnant and postpartum cocaine misusers.
    Ball SA; Schottenfeld RS
    Subst Use Misuse; 1997 Jan; 32(1):25-41. PubMed ID: 9044535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial characteristics of pregnant women with and without a history of substance abuse.
    Marcenko MO; Spence M; Rohweder C
    Health Soc Work; 1994 Feb; 19(1):17-22. PubMed ID: 8168773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A description of the Maternal Addiction Program of the University of Miami/Jackson Memorial Medical Center.
    Malow RM; Ireland SJ; Halpert ES; Szapocznik J; McMahon RC; Haber L
    J Subst Abuse Treat; 1994; 11(1):55-60. PubMed ID: 8201634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mood symptoms in pregnant and postpartum women with bipolar disorder: a naturalistic study.
    Driscoll KE; Sit DKY; Moses-Kolko EL; Pinheiro E; Yang A; Ciolino JD; Eng HF; Luther JF; Clark CT; Wisniewski SR; Wisner KL
    Bipolar Disord; 2017 Jun; 19(4):295-304. PubMed ID: 28665044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.